Tissue targeted antigenic activation of the immune response to treat cancers
US10086066B2 · kind B2 · utility
1Cited by
10References
14Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 17, 2016 |
| Grant date | Oct 2, 2018 |
| Priority date | — |
| Expiry date | Mar 17, 2036 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides in part methods of treating cancers of a specific organ or tissue by administering a composition that is antigenically specific for one or more microbes that are pathogenic in the specific organ or tissue in which the cancer is situated.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.